Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date

Total article views   HTML views PDF downloads Totals
3,924 Dovepress* 3,444+ 701 4,145
PubMed Central* 480 150 630
Totals 3,924 851 4,775
*Since 25 September 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar